19-2434052-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP3
The NM_032737.4(LMNB2):c.1256C>G(p.Ser419Trp) variant causes a missense change. The variant allele was found at a frequency of 0.00000812 in 1,600,362 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032737.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMNB2 | ENST00000325327.4 | c.1256C>G | p.Ser419Trp | missense_variant | Exon 8 of 12 | 1 | NM_032737.4 | ENSP00000327054.3 | ||
LMNB2 | ENST00000490554.5 | n.447C>G | non_coding_transcript_exon_variant | Exon 3 of 4 | 2 | |||||
LMNB2 | ENST00000532465.1 | n.-153C>G | upstream_gene_variant | 3 | ||||||
LMNB2 | ENST00000527409.1 | n.*243C>G | downstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000182 AC: 4AN: 219784Hom.: 0 AF XY: 0.0000166 AC XY: 2AN XY: 120698
GnomAD4 exome AF: 0.00000760 AC: 11AN: 1448134Hom.: 0 Cov.: 36 AF XY: 0.00000695 AC XY: 5AN XY: 719664
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152228Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74372
ClinVar
Submissions by phenotype
Lipodystrophy, partial, acquired, susceptibility to;C4225289:Progressive myoclonic epilepsy type 9 Uncertain:1
In summary, this variant has uncertain impact on LMNB2 function. The available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with an LMNB2-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces serine with tryptophan at codon 419 of the LMNB2 protein (p.Ser419Trp). The serine residue is highly conserved and there is a large physicochemical difference between serine and tryptophan. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at